Overview

Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements

Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess whether myocardial perfusion reserve, measured during routine clinically ordered regadenoson stress cardiac magnetic resonance (CMR) has prognostic value in predicting adverse cardiovascular events. Myocardial perfusion reserve will be measured with CMR by assessing blood flow through the coronary-sinus - the primary vein in the heart.
Details
Lead Sponsor:
University of Illinois at Chicago
Collaborator:
Astellas Pharma Inc
Treatments:
Regadenoson